Saw Palmetto Max-V
On sale on the US market (according to the DSLD)
Douglas Laboratories, food supplement from the US market
Saw Palmetto Max-V (Douglas Laboratories), a food supplement au code-barres 310539001257, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Douglas Laboratories
- Barcode
- 310539001257
- Form
- Capsule
- One serving
- 1 vegetarian capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Vegetable Stearate, Silica, Microcrystalline Cellulose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Saw Palmetto Herbal Extract (Serenoa repens) | Plant | 160 mg |
| Saw Palmetto (Serenoa repens) | Plant | 100 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Saw Palmetto Max-V
Entered into DSLD on 26 February 2014. Withdrawn from the US market on 18 May 2020 (according to the DSLD).- Active ingredient added : Standardized to provide 48 mg fatty acids (48 mg)
Official label: Saw Palmetto Max-V
Entered into DSLD on 21 December 2012. Withdrawn from the US market on 31 July 2013 (according to the DSLD).- Active ingredient added : Standardized to provide 48 mg fatty acids (48 mg)
Official label: Saw Palmetto Max-V
Entered into DSLD on 1 June 2012. Withdrawn from the US market on 16 November 2012 (according to the DSLD).Same active composition.
Official label: Saw Palmetto Max-V
Entered into DSLD on 25 January 2012. Withdrawn from the US market on 20 January 2012 (according to the DSLD).Same active composition.
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Saw Palmetto Herbal Extract
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Douglas Laboratories
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Saw Palmetto Max-V (Douglas Laboratories): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/310539001257-saw-palmetto-max-v-douglas-laboratories, updated 23 August 2020.